Itonic (ITOC) Stock Price, News & Analysis

Company Overview

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Key Stats

• Today's Range: $3.76 to $4.04
• 50-Day Range: $3.58 to $5.28
• 52-Week Range: $3.42 to $18.40
• Volume: 38,627 shs
• Average Volume: 71,392 shs
• Market Capitalization: $27.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Itonic Stock Analysis - MarketRank™

Itonic scored higher than 6% of companies evaluated by MarketBeat, and ranked 853rd out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Itonic has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Itonic has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Itonic has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

19.36% of the float of Itonic has been sold short.

Short Interest Ratio / Days to Cover

Itonic has a short interest ratio ("days to cover") of 0.12, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Itonic has recently increased by 228.58%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Itonic does not currently pay a dividend.

Dividend Growth

Itonic does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.16

News Sentiment

Itonic has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Itonic this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for ITOC on MarketBeat in the last 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Itonic insiders have not sold or bought any company stock.

Percentage Held by Institutions

Itonic has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 9/30/2026
• Today: 10/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:ITOC
• Previous Symbol: NASDAQ:PTHL
• CIK: 1970544
• Web: www.ftzy.com.cn
• Phone: 010-84817665
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 17.40
• Quick Ratio: 17.36

Sales & Book Value

• Annual Sales: $556.43 thousand
• Price / Sales: 49.96
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7.63 per share
• Price / Book: 0.50

Miscellaneous

• Outstanding Shares: 7,316,000
• Free Float: N/A
• Market Cap: $27.80 million
• Optionable: N/A
• Beta: 2.83